IMS Health (IMS) Tops Q1 EPS by 4c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/1/2026
- Wall Street ends higher as Amazon soothes AI jitters
- Amazon shares rally as cloud growth surges and spending outlook climbs
- Apple shares sink on disappointing September quarter sales outlook
- Novo Nordisk stock tumbles 10% as key trial misses goal
- AI wizkid Leopold Aschenbrenner forced to sell entire portfolio after rout
- SCYNEXIS (SCYX) Move Attributed to Morning Note from Brookline
- AbbVie (ABBV) Misses Q2 EPS by 6c, Beats on Revenue; Offers FY26 EPS Guidance
- Short sellers pile into SpaceX ahead of earnings, lockup expiration
- Wall Street ends higher as Amazon soothes AI jitters
- Novo Nordisk's ziltivekimab fails to reduce heart risk in ZEUS trial
- After-Hours Stock Movers: AAPL, AMZN, COIN, RBLX, RDDT, AXTI, FND, WU, GDDY
- After-Hours Stock Movers: META, MSFT, CMG, SBUX, CVNA, LRCX, FTNT, QCOM, TDOC
- After-Hours Stock Movers: F, BE, STX, WDC, KLAC, SWKS, NXPI, CSGP, ENPH
- After-Hours Stock Movers: FFIV, CDNS, APLD, RMBS, ESI, SANM
- After-Hours Stock Movers: INTC, AMD, ARM, MXL, EW, DECK
IMS Health Reports First-Quarter 2016 Results
May 3, 2016 6:15 AM EDTRevenue up 25.2 percent at constant currency Adjusted EBITDA up 9.4 percent at constant currency Adjusted Net Income up 6.4 percent at constant currency Adjusted Diluted Earnings per Share was $0.42 reported, up 9.5 percent at constant currency Constant currency guidance reaffirmed, reported guidance raised
DANBURY, Conn.--(BUSINESS WIRE)-- IMS Health Holdings, Inc. (IMS Health) (NYSE: IMS), a leading global provider of information and technology services to the healthcare and life sciences industries, today announced... More
IMS Health and Quintiles to Merge; Quintiles IMS to Become Industry-Leading Information and Technology-Enabled Healthcare Service Provider
May 3, 2016 6:00 AM EDTAll-stock transaction with combined 2015 revenue of $7.2 billion and combined equity market capitalization of $17.6 billion
Broad range of healthcare information, technology and services solutions to drive efficiencies and insights across the entire life sciences product lifecycle, from R&D through commercial execution to real-world patient outcomes. Capabilities to address mission-critical healthcare operations with a market opportunity of more than $230 billion. Quintiles IMS will: Accelerate patient access to innovative medicines by increasing the productivity of the $100 billion spent on drug development Demonstrate the value... MoreIMS Health and Quintiles to Merge
May 3, 2016 6:00 AM EDTQuintiles IMS to Become Industry-Leading Information and Technology-Enabled Healthcare Service Provider
All-Stock Transaction with Combined 2015 Revenue of $7.2 Billion and Combined Equity Market Capitalization of $17.6 Billion
DANBURY, Conn. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- IMS Health Holdings, Inc. (NYSE: IMS) and Quintiles Transnational Holdings Inc. (NYSE: Q):
This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20160503005889/en/
... More